We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Cytokines Regulate Development of Immune System Memory Cells

By LabMedica International staff writers
Posted on 09 Jun 2009
The process of developing new vaccines should be facilitated by the discovery that two different cytokines regulate the formation of the CD8+ T-cells that "remember” pathogens and allow the immune system to quickly respond to any subsequent infection.

Investigators from the University of Texas Southwestern Medical School (Dallas, USA) studied how two cytokines, interleukin-21 (IL-21) and interferon, affected the development of immune T-cells in response to infection. More...
They reported in the May 28, 2009, issue of the journal Blood that IL-12 exclusively promoted the development of interferon-gamma and tumor necrosis factor (TNF) secreting T effector memory (TEM) cells, whereas interferon drove the development of T central memory (TCM) cells.

The development of TEM and TCM was linked to cell division. In rapidly dividing cells, IL-12 programmed TEM through induction of the IL-12 receptor beta-2. In contrast, interferon regulated TCM development by slowing the progression of cell division in a subpopulation of cells that selectively expressed elevated interferon receptor-2. In the presence of both IL-12 and interferon, these cytokine signals promoted the simultaneous development of both TCM and TEM.

"Until now, no innate signals have been identified that regulate the development of memory cells,” said senior author Dr. David Farrar, assistant professor of immunology at the University of Texas Southwestern Medical Center. "Our study is the first to identify the signals that promote the development of these memory cells when you first get infected. Regardless of the precise mechanism, what we know now is that you can develop both long-term and immediate memory cells at the same time.”

"There are some vaccines that are extremely effective, while others are only moderately effective,” Dr. Farrar said. "If we can isolate pools of antigen-specific memory cells, we should be able to determine what it is about those pools of memory cells that is different between an extremely effective vaccine and one that's not so effective. If we can figure that out, then we can start to think about altering our approach to vaccinating based on the different type of microorganism that we're trying to vaccinate against.”

Related Links:
University of Texas Southwestern Medical School



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.